|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income for the year | |||||
| Adjustments to reconcile net income for the year to net cash flows from operating activities: | |||||
| Share-based compensation expense | |||||
| Current income tax (note 9.1) | |||||
| Deferred income tax (note 9.1) | |||||
| Depreciation of property and equipment (note 15) | |||||
| Depreciation of right-of-use assets (note 28) | |||||
| Amortization of intangible assets (note 16) | |||||
| Impairment/(Reversal) of intangible assets, net (note 16) | |||||
| Remeasurement at fair value of investment in associates | |||||
| Net impairment losses on financial assets | |||||
| Reversal for claims and lawsuits (note 23) | |||||
| Loss (gain) on remeasurement of contingent consideration and liabilities in installments (note 8) | |||||
| Gain on transactions with bonds (note 7) | |||||
| Accrued interest | |||||
| Interest received | |||||
| Net gain arising on financial assets measured at FVPL | |||||
| Net (gain) loss arising on financial assets measured at FVOCI | |||||
| Exchange differences | |||||
| Share of results of investment in associates | |||||
| Payments related to forward and future contracts | |||||
| Proceeds related to forward and future contracts | |||||
| Payments of remeasured earn-outs related to acquisition of business | |||||
| Gain arising from sale of cryptocurrency | |||||
| Net impairment losses on investments in convertible notes | |||||
| Loss (gain) arising from lease disposals | |||||
| Loss arising from property and equipment and intangibles derecognition | |||||
| Changes in working capital: | |||||
| Net decrease (increase) in trade receivables | |||||
| Net (increase) decrease in other receivables | |||||
| Net (increase) decrease in other assets | |||||
| Net increase (decrease) in trade payables | |||||
| Net (decrease) increase in payroll and social security taxes payable | |||||
| Net decrease in tax liabilities | |||||
| Utilization of provision for contingent liabilities (note 23) | |||||
| Income tax paid | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Cash outflows for property and equipment | |||||
| Proceeds from sale of cryptocurrency | |||||
| Cash outflows for intangible assets | |||||
| Acquisition of investment in sovereign bonds | |||||
| Proceeds from investment in sovereign bonds | |||||
| Payments related to forward and future contracts | |||||
| Proceeds related to forward and future contracts | |||||
| Acquisition of investments measured at FVPL | |||||
| Proceeds from investments measured at FVPL | |||||
| Acquisition of investments measured at FVOCI | |||||
| Proceeds from investments measured at FVOCI | |||||
| Proceeds from sale of equity instruments | |||||
| Payments to acquire equity instruments | |||||
| Payments to acquire investments in associates | |||||
| Dividends from investments in associates | |||||
| Acquisition of investment in convertible notes (note 29) | |||||
| Collection of investments in convertible notes | |||||
| Acquisition of business, net of cash (note 26) | |||||
| Payments of earn-outs related to acquisition of business | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the issuance of common shares pursuant to May 2021 Public Offering, net of costs | |||||
| Proceeds from the issuance of shares under the share-based compensation plan (note 30.1) | |||||
| Proceeds from the issuance of shares under the ESPP plan | |||||
| Repurchase of shares | |||||
| Payment of call/put-option over non-controlling interest | |||||
| Proceeds from borrowings (note 21) | |||||
| Repayment of borrowings (note 21) | |||||
| Payments of principal portion of lease liabilities (note 28) | |||||
| Payments of lease liabilities interest (note 28) | |||||
| Interest paid (note 21) | |||||
| Payments of installments related to acquisition of business | |||||
| Net cash (used in) provided by financing activities | |||||
| Increase (Decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents at end of the year | |||||
| Cash paid | |||||
| Total consideration paid net of cash and cash equivalents acquired | |||||
Loading...